Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Today 6:16 PM View:  | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | Today | Sale | 33,061 | $3.30 | $109,161.00 | (< 1%) 5.27M to 5.24M | |
| Today 6:16 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | Yesterday | Sale | 20,535 | $3.12 | $63,980.90 | (< 1%) 5.29M to 5.27M | |
| Today 6:16 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 29-Apr-24 | Sale | 6,403 | $3.25 | $20,792.50 | (< 1%) 5.3M to 5.29M | |
| 24-Apr-24 5:50 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 24-Apr-24 | Sale | 8,064 | $3.50 | $28,250.60 | (< 1%) 4.08M to 4.07M | |
| 24-Apr-24 5:50 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 23-Apr-24 | Sale | 22,000 | $3.49 | $76,799.80 | (< 1%) 4.1M to 4.08M | |
| 24-Apr-24 5:50 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 22-Apr-24 | Sale | 14,331 | $3.53 | $50,597.00 | (< 1%) 4.11M to 4.1M | |
| 18-Apr-24 5:00 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 17-Apr-24 | Sale | 22,737 | $3.71 | $84,424.80 | (< 1%) 4.14M to 4.11M | |
| 18-Apr-24 5:00 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 16-Apr-24 | Sale | 48,683 | $3.53 | $171,802.00 | (1%) 4.19M to 4.14M | |
| 18-Dec-23 4:15 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 15-Dec-23 | Private Sale | 32,535 | $13.16 | $428,180.00 | (100%) 32.53K to 0 | |
| 14-Dec-23 8:58 PM View: | Thomas John Director | Genelux Corp (GNLX) | 13-Dec-23 | Private Sale | 9,000 | $13.38 | $120,387.00 | (2%) 472.46K to 463.46K | |
| 14-Dec-23 8:59 PM View: | Tyree James L Director | Genelux Corp (GNLX) | 13-Dec-23 | Private Sale | 9,000 | $13.22 | $118,969.00 | (72%) 12.46K to 3.46K | |
| 08-Dec-23 5:57 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 07-Dec-23 | Private Sale | 36,800 | $11.85 | $435,995.00 | (53%) 69.33K to 32.53K | |
| 22-Nov-23 4:15 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 21-Nov-23 | Private Sale | 18,665 | $10.26 | $191,555.00 | (21%) 88.0K to 69.33K | |
| 21-Nov-23 10:00 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 20-Nov-23 | Sale | 14,594 | $11.26 | $164,261.00 | (14%) 102.59K to 88.0K | |
| 21-Nov-23 10:00 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 17-Nov-23 | Private Sale | 3,541 | $13.04 | $46,169.70 | (3%) 106.14K to 102.59K | |
| 26-Oct-23 5:07 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 25-Oct-23 | Private Sale | 5,704 | $19.40 | $110,638.00 | (< 1%) 4.19M to 4.19M | |
| 25-Oct-23 4:15 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 24-Oct-23 | Planned Private Option Sale | 5,200 | $19.11 | $99,351.20 | (5%) 111.33K to 106.14K | |
| 25-Oct-23 4:15 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 24-Oct-23 | Option Exercise | 5,200 | $6.00 | $31,200.00 | 5% 106.14K to 111.33K | (5%) |
| 25-Oct-23 4:51 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 23-Oct-23 | Private Sale | 49,987 | $19.97 | $998,365.00 | (1%) 4.24M to 4.19M | |
| 16-Oct-23 6:39 PM View: | Thomas John Director | Genelux Corp (GNLX) | 16-Oct-23 | Private Sale (Planned) | 3,333 | $20.71 | $69,038.00 | (< 1%) 475.79K to 472.46K | |
| 11-Oct-23 4:10 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 10-Oct-23 | Planned Private Option Sale | 5,200 | $22.01 | $114,462.00 | (5%) 111.33K to 106.14K | |
| 11-Oct-23 4:10 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 10-Oct-23 | Option Exercise | 5,200 | $6.00 | $31,200.00 | 5% 106.14K to 111.33K | (5%) |
| 10-Oct-23 4:49 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 05-Oct-23 | Private Sale | 14,251 | $24.93 | $355,229.00 | (< 1%) 4.26M to 4.24M | |
| 04-Oct-23 6:43 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 03-Oct-23 | Private Sale | 75,690 | $25.49 | $1,929,220.00 | (2%) 4.33M to 4.26M | |
| 29-Sep-23 4:34 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 28-Sep-23 | Sale | 2,289 | $24.12 | $55,210.70 | (< 1%) 4.33M to 4.33M | |
| 29-Sep-23 4:34 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 27-Sep-23 | Private Sale | 11,257 | $24.47 | $275,459.00 | (< 1%) 4.34M to 4.33M | |
| 27-Sep-23 4:33 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 26-Sep-23 | Sale | 29,805 | $23.79 | $709,177.00 | (< 1%) 4.37M to 4.34M | |
| 27-Sep-23 4:10 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 26-Sep-23 | Planned Private Option Sale | 5,200 | $23.56 | $122,528.00 | (5%) 111.33K to 106.14K | |
| 27-Sep-23 4:10 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 26-Sep-23 | Option Exercise | 5,200 | $6.00 | $31,200.00 | 5% 106.14K to 111.33K | (5%) |
| 27-Sep-23 4:33 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 25-Sep-23 | Private Sale | 12,458 | $25.77 | $321,004.00 | (< 1%) 4.39M to 4.37M | |
| 25-Sep-23 6:30 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 22-Sep-23 | Sale | 9,042 | $27.33 | $247,123.00 | (< 1%) 4.4M to 4.39M | |
| 25-Sep-23 6:30 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 21-Sep-23 | Private Sale | 7,549 | $28.46 | $214,878.00 | (< 1%) 4.4M to 4.4M | |
| 21-Sep-23 4:30 PM View: | Ryder Sean General Counsel | Genelux Corp (GNLX) | 20-Sep-23 | Option Exercise | 10,000 | $6.00 | $60,000.00 | 1748% 0.57K to 10.57K | (5%) |
| 21-Sep-23 4:35 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 20-Sep-23 | Planned Private Option Sale | 6,000 | $27.96 | $167,786.00 | (5%) 112.14K to 106.14K | |
| 21-Sep-23 4:35 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 20-Sep-23 | Option Exercise | 6,000 | $6.00 | $36,000.00 | 6% 106.14K to 112.14K | (5%) |
| 21-Sep-23 4:30 PM View: | Ryder Sean General Counsel | Genelux Corp (GNLX) | 20-Sep-23 | Planned Private Option Sale | 10,000 | $30.00 | $300,000.00 | (95%) 10.57K to 0.57K | |
| 20-Sep-23 4:48 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 19-Sep-23 | Sale | 32,167 | $26.45 | $850,942.00 | (< 1%) 4.44M to 4.4M | |
| 18-Sep-23 8:12 PM View: | Thomas John Director | Genelux Corp (GNLX) | 18-Sep-23 | Sale (Planned) | 3,334 | $24.99 | $83,316.70 | (< 1%) 479.13K to 475.79K | |
| 20-Sep-23 4:48 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 18-Sep-23 | Private Sale | 30,292 | $23.29 | $705,649.00 | (< 1%) 4.47M to 4.44M | |
| 18-Sep-23 8:13 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 15-Sep-23 | Option Exercise | 10,400 | $6.00 | $62,400.00 | 10% 106.14K to 116.53K | (5%) |
| 18-Sep-23 8:13 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 15-Sep-23 | Planned Private Option Sale | 10,400 | $21.89 | $227,630.00 | (9%) 116.53K to 106.14K | |
| 18-Sep-23 8:12 PM View: | Thomas John Director | Genelux Corp (GNLX) | 15-Sep-23 | Private Sale (Planned) | 3,333 | $21.90 | $72,996.00 | (< 1%) 482.46K to 479.13K | |
| 15-Sep-23 4:19 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 14-Sep-23 | Sale | 25,276 | $22.07 | $557,806.00 | (< 1%) 4.49M to 4.47M | |
| 15-Sep-23 4:19 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 13-Sep-23 | Private Sale | 19,032 | $21.44 | $408,093.00 | (< 1%) 4.51M to 4.49M | |
| 14-Sep-23 8:18 PM View: | Smither John W Director | Genelux Corp (GNLX) | 13-Sep-23 | Private Sale | 900 | $20.78 | $18,702.00 | (12%) 7.82K to 6.92K | |
| 15-Sep-23 8:06 PM View: | Yu Tony VP, Clinical Trial Operations | Genelux Corp (GNLX) | 13-Sep-23 | Private Sale | 29,800 | $21.14 | $629,927.00 | (22%) 135.94K to 106.14K | |
| 13-Sep-23 7:04 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 12-Sep-23 | Sale | 20,265 | $22.26 | $451,167.00 | (< 1%) 4.53M to 4.51M | |
| 13-Sep-23 8:14 PM View: | Smither John W Director | Genelux Corp (GNLX) | 11-Sep-23 | Grant | 6,920 | -- | -- | 769% 0.9K to 7.82K | |
| 12-Sep-23 4:22 PM View: | Smalling Ralph Head of Regulatory | Genelux Corp (GNLX) | 11-Sep-23 | Grant | 10,000 | -- | -- | 484% 2.06K to 12.06K | |
| 13-Sep-23 7:04 PM View: | Szalay Aladar 10% Owner | Genelux Corp (GNLX) | 11-Sep-23 | Private Sale | 32,351 | $22.22 | $718,702.00 | (< 1%) 4.56M to 4.53M |
